Literature DB >> 25066378

Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing.

Tao Xie1, Yong Beom Cho2, Kai Wang3, Donghui Huang4, Hye Kyung Hong5, Yoon-La Choi6, Young Hyeh Ko7, Do-Hyun Nam8, Juyoun Jin9, Heekyoung Yang10, Julio Fernandez11, Shibing Deng12, Paul A Rejto13, Woo Yong Lee14, Mao Mao15.   

Abstract

Colorectal cancer (CRC) patients have poor prognosis after formation of distant metastasis. Understanding the molecular mechanisms by which genetic changes facilitate metastasis is critical for the development of targeted therapeutic strategies aimed at controlling disease progression while minimizing toxic side effects. A comprehensive portrait of somatic alterations in CRC and the changes between primary and metastatic tumors has yet to be developed. We performed whole genome sequencing of two primary CRC tumors and their matched liver metastases. By comparing to matched germline DNA, we catalogued somatic alterations at multiple scales, including single nucleotide variations, small insertions and deletions, copy number aberrations and structural variations in both the primary and matched metastasis. We found that the majority of these somatic alterations are present in both sites. Despite the overall similarity, several de novo alterations in the metastases were predicted to be deleterious, in genes including FBXW7, DCLK1 and FAT2, which might contribute to the initiation and progression of distant metastasis. Through careful examination of the mutation prevalence among tumor cells at each site, we also proposed distinct clonal evolution patterns between primary and metastatic tumors in the two cases. These results suggest that somatic alterations may play an important role in driving the development of colorectal cancer metastasis and present challenges and opportunities when considering the choice of treatment.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Metastasis; Somatic alteration; Whole genome sequencing

Mesh:

Substances:

Year:  2014        PMID: 25066378     DOI: 10.1016/j.ygeno.2014.07.012

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  29 in total

1.  The gene mutational discrepancies between primary and paired metastatic colorectal carcinoma detected by next-generation sequencing.

Authors:  Shuang-Mei Zou; Wei-Hua Li; Wen-Miao Wang; Wen-Bin Li; Su-Sheng Shi; Jian-Ming Ying; Ning Lyu
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-31       Impact factor: 4.553

Review 2.  Genetic insights into the morass of metastatic heterogeneity.

Authors:  Kent W Hunter; Ruhul Amin; Sarah Deasy; Ngoc-Han Ha; Lalage Wakefield
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

Review 3.  Tumor evolution and intratumor heterogeneity in colorectal carcinoma: insights from comparative genomic profiling of primary tumors and matched metastases.

Authors:  Brooke E Sylvester; Efsevia Vakiani
Journal:  J Gastrointest Oncol       Date:  2015-12

4.  Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer.

Authors:  Rebeca Sanz-Pamplona; Adriana Lopez-Doriga; Laia Paré-Brunet; Kira Lázaro; Fernando Bellido; M Henar Alonso; Susanna Aussó; Elisabet Guinó; Sergi Beltrán; Francesc Castro-Giner; Marta Gut; Xavier Sanjuan; Adria Closa; David Cordero; Francisco D Morón-Duran; Antonio Soriano; Ramón Salazar; Laura Valle; Victor Moreno
Journal:  Clin Cancer Res       Date:  2015-06-12       Impact factor: 12.531

Review 5.  Engineering Multidimensional Evolutionary Forces to Combat Cancer.

Authors:  Caroline E McCoach; Trever G Bivona
Journal:  Cancer Discov       Date:  2019-04-16       Impact factor: 39.397

Review 6.  Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers.

Authors:  H Wang; L Liang; J-Y Fang; J Xu
Journal:  Oncogene       Date:  2015-08-10       Impact factor: 9.867

Review 7.  The role of individual inheritance in tumor progression and metastasis.

Authors:  Kent Hunter
Journal:  J Mol Med (Berl)       Date:  2015-06-10       Impact factor: 4.599

8.  Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.

Authors:  Priscilla K Brastianos; Scott L Carter; Gad Getz; William C Hahn; Sandro Santagata; Daniel P Cahill; Amaro Taylor-Weiner; Robert T Jones; Eliezer M Van Allen; Michael S Lawrence; Peleg M Horowitz; Kristian Cibulskis; Keith L Ligon; Josep Tabernero; Joan Seoane; Elena Martinez-Saez; William T Curry; Ian F Dunn; Sun Ha Paek; Sung-Hye Park; Aaron McKenna; Aaron Chevalier; Mara Rosenberg; Frederick G Barker; Corey M Gill; Paul Van Hummelen; Aaron R Thorner; Bruce E Johnson; Mai P Hoang; Toni K Choueiri; Sabina Signoretti; Carrie Sougnez; Michael S Rabin; Nancy U Lin; Eric P Winer; Anat Stemmer-Rachamimov; Matthew Meyerson; Levi Garraway; Stacey Gabriel; Eric S Lander; Rameen Beroukhim; Tracy T Batchelor; Jose Baselga; David N Louis
Journal:  Cancer Discov       Date:  2015-09-26       Impact factor: 39.397

9.  Comparison of EpCAMhighCD44+ cancer stem cells with EpCAMhighCD44- tumor cells in colon cancer by single-cell sequencing.

Authors:  Mingshan Liu; Jiabo Di; Yang Liu; Zhe Su; Beihai Jiang; Zaozao Wang; Xiangqian Su
Journal:  Cancer Biol Ther       Date:  2018-04-12       Impact factor: 4.742

10.  TNFRSF10C copy number variation is associated with metastatic colorectal cancer.

Authors:  Daniel G Tanenbaum; William A Hall; Lauren E Colbert; Amanda J Bastien; Daniel J Brat; Jun Kong; Sungjin Kim; Bhakti Dwivedi; Jeanne Kowalski; Jerome C Landry; David S Yu
Journal:  J Gastrointest Oncol       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.